BeOne Medicines
ONC
#735
Rank
โ‚น3.264 T
Marketcap
โ‚น31,466
Share price
-0.27%
Change (1 day)
22.80%
Change (1 year)
BeOne Medicines formerly known as BeiGene, is a multinational pharmaceutical company engaged in the R&D, commercialization of molecularly-targeted, and immuno-oncology drugs for the treatment of cancer.

Earnings for BeOne Medicines (ONC)

Earnings in 2026 (TTM): โ‚น68.45 Billion

According to BeOne Medicines's latest financial reports the company's current earnings are โ‚น5.73 Billion. In 2025 the company made an earning of โ‚น47.49 Billion, an increase over its 2024 earnings that were of -โ‚น54.87 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for BeOne Medicines from 2015 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) โ‚น68.45 B44.13%
2025 โ‚น47.49 B-186.57%
2024 -โ‚น54.87 Billion-52.95%
2023 -โ‚น116.61 Billion-32.52%
2022 -โ‚น172.8 Billion24.39%
2021 -โ‚น138.92 Billion-13.21%
2020 -โ‚น160.06 Billion72.69%
2019 -โ‚น92.68 Billion36.01%
2018 -โ‚น68.15 Billion616.83%
2017 -โ‚น9.51 Billion-15.24%
2016 -โ‚น11.22 Billion107.91%
2015 -โ‚น5.4 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
OPKO Health
OPK
-โ‚น22.11 Billion-130.28%๐Ÿ‡บ๐Ÿ‡ธ USA
Onconova Therapeutics
ONTX
-โ‚น1.76 Billion-102.40%๐Ÿ‡บ๐Ÿ‡ธ USA